Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 19, Status: Authorised

PSUSA/00003006/202503

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Revision: 2, Status: Authorised

Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Date of authorisation: 20/09/2018, Revision: 10, Status: Authorised

COVID-19 vaccines: key facts

LinkedIn Live: How EMA supports innovation in medicine development, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2026, 14:30 (CET) to 25 February 2026, 15:00 (CET)

Medicines during pregnancy and breastfeeding

Human medicines European public assessment report (EPAR): Azarga, brinzolamide,timolol, Date of authorisation: 25/11/2008, Revision: 19, Status: Authorised